Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the lenvatinib and pembrolizumab thyroid cancer study is displayed, with its study details, eligibility criteria, outcomes, locations, and documents.
    Difference
    67%
    Check dated 2026-11-08T13:00:11.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:26:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website changes and saying that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T13:08:19.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T13:19:25.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:10:04.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error rather than the study details, indicating access is blocked or restricted. This prevents viewing the trial information while the underlying data remains unchanged.
    Difference
    20%
    Check dated 2026-09-20T12:28:39.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.